Work

Time to enhance COVID-19 vaccination in women of reproductive age

Year: 2024

Type: article

Abstract: Previous evidence, including major works from the Intercovid multinational consortium, showed that COVID-19 in pregnancy is associated with adverse maternal and neonatal outcomes such as hypertensive disorders, preterm birth (particularly with iatrogenic aetiology), gestational diabetes, foetal distress and reduced foetal growth.1–4 In contrast, pregnant women with complete or boosted vaccination status showed reduced risks of severe morbidity and complications compared to unvaccinated, underscoring the importance of vaccination coverage.

Source: The Lancet Regional Health - Europe

DOI: 10.1016/j.lanepe.2024.101069

Authors: Paolo I. Cavoretto, Antonio Farina

Institutions: Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Bologna

Language: English

Topic: COVID-19 Impact on Reproduction

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,000